Latest SPHERA FUNDS MANAGEMENT LTD. Stock Portfolio
$711Million– No. of Holdings #93
SPHERA FUNDS MANAGEMENT LTD. Performance:
2024 Q1: 12.3%YTD: 12.3%2023: 8%
Performance for 2024 Q1 is 12.3%, and YTD is 12.3%, and 2023 is 8%.
About SPHERA FUNDS MANAGEMENT LTD. and 13F Hedge Fund Stock Holdings
SPHERA FUNDS MANAGEMENT LTD. is a hedge fund based in NEW YORK, NY. On 31-Mar-2022, the fund reported that it had an AUM (Regulated Assets under Management) of $789.8 Millions. In it's latest 13F Holdings report, SPHERA FUNDS MANAGEMENT LTD. reported an equity portfolio of $711.7 Millions as of 31 Mar, 2024.
The top stock holdings of SPHERA FUNDS MANAGEMENT LTD. are TEVA, SNY, NICE. The fund has invested 3.8% of it's portfolio in TEVA PHARMACEUTICAL INDS LTD and 3.4% of portfolio in SANOFI.
The fund managers got completely rid off INHIBRX INC (INBX), PRAXIS PRECISION MEDICINES I (PRAX) and MADRIGAL PHARMACEUTICALS INC (MDGL) stocks. They significantly reduced their stock positions in CARTESIAN THERAPEUTICS INC (SELB), ASTRIA THERAPEUTICS INC (ATXS) and ALPINE IMMUNE SCIENCES INC (ALPN). SPHERA FUNDS MANAGEMENT LTD. opened new stock positions in JASPER THERAPEUTICS INC (JSPR), PRAXIS PRECISION MEDICINES I (PRAX) and CYBIN INC (CYBN). The fund showed a lot of confidence in some stocks as they added substantially to PERSPECTIVE THERAPEUTICS INC, VENTYX BIOSCIENCES INC (VTYX) and SAREPTA THERAPEUTICS INC (SRPT).
The top stock holdings of SPHERA FUNDS MANAGEMENT LTD. are TEVA, SNY, NICE. The fund has invested 3.8% of it's portfolio in TEVA PHARMACEUTICAL INDS LTD and 3.4% of portfolio in SANOFI.
The fund managers got completely rid off INHIBRX INC (INBX), PRAXIS PRECISION MEDICINES I (PRAX) and MADRIGAL PHARMACEUTICALS INC (MDGL) stocks. They significantly reduced their stock positions in CARTESIAN THERAPEUTICS INC (SELB), ASTRIA THERAPEUTICS INC (ATXS) and ALPINE IMMUNE SCIENCES INC (ALPN). SPHERA FUNDS MANAGEMENT LTD. opened new stock positions in JASPER THERAPEUTICS INC (JSPR), PRAXIS PRECISION MEDICINES I (PRAX) and CYBIN INC (CYBN). The fund showed a lot of confidence in some stocks as they added substantially to PERSPECTIVE THERAPEUTICS INC, VENTYX BIOSCIENCES INC (VTYX) and SAREPTA THERAPEUTICS INC (SRPT).
SPHERA FUNDS MANAGEMENT LTD. Equity Portfolio Value
Last Reported on: 15 May, 2024
SPHERA FUNDS MANAGEMENT LTD. Annual Return Estimates Vs S&P 500
Our best estimate is that SPHERA FUNDS MANAGEMENT LTD. made a return of 12.3% in the last quarter. In trailing 12 months, it's portfolio return was 24.88%.
New Buys
| Ticker | $ Bought |
|---|---|
| jasper therapeutics inc | 14,833,900 |
| praxis precision medicines i | 10,809,000 |
| cybin inc | 10,577,900 |
| outlook therapeutics inc | 6,822,860 |
| applied matls inc | 6,599,360 |
| camtek ltd | 6,275,130 |
| 4d molecular therapeutics in | 5,166,450 |
| catalyst pharmaceuticals inc | 4,590,720 |
New stocks bought by SPHERA FUNDS MANAGEMENT LTD.
Additions
| Ticker | % Inc. |
|---|---|
| perspective therapeutics inc | 48,373 |
| ventyx biosciences inc | 451 |
| sarepta therapeutics inc | 344 |
| vigil neuroscience inc | 223 |
| prime medicine inc | 177 |
| sentinelone inc | 158 |
| bridgebio pharma inc | 107 |
| jfrog ltd | 104 |
Additions to existing portfolio by SPHERA FUNDS MANAGEMENT LTD.
Reductions
| Ticker | % Reduced |
|---|---|
| cartesian therapeutics inc | -96.67 |
| astria therapeutics inc | -90.2 |
| alpine immune sciences inc | -80.91 |
| advanced micro devices inc | -78.17 |
| nova ltd | -73.4 |
| icl group ltd | -68.93 |
| tower semiconductor ltd | -66.00 |
| springworks therapeutics inc | -58.73 |
SPHERA FUNDS MANAGEMENT LTD. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| rigel pharmaceuticals inc | -1,780,780 |
| gracell biotechnologies inc | -5,049,480 |
| praxis precision medicines i | -7,329,810 |
| cogent biosciences inc | -1,524,100 |
| inhibrx inc | -8,608,940 |
| arrowhead pharmaceuticals in | -4,433,910 |
| ptc therapeutics inc | -3,762,630 |
| oric pharmaceuticals inc | -1,166,560 |
SPHERA FUNDS MANAGEMENT LTD. got rid off the above stocks
Sector Distribution
SPHERA FUNDS MANAGEMENT LTD. has about 54.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 54.9 |
| Others | 31.1 |
| Technology | 10.2 |
| Communication Services | 2 |
| Consumer Cyclical | 1.6 |
Market Cap. Distribution
SPHERA FUNDS MANAGEMENT LTD. has about 25.6% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 31.1 |
| SMALL-CAP | 19.7 |
| MID-CAP | 16.9 |
| MEGA-CAP | 14.1 |
| LARGE-CAP | 11.5 |
| MICRO-CAP | 5.8 |
Stocks belong to which Index?
About 0% of the stocks held by SPHERA FUNDS MANAGEMENT LTD. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 100 |
SPHERA FUNDS MANAGEMENT LTD. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of SPHERA FUNDS MANAGEMENT LTD.
SPHERA FUNDS MANAGEMENT LTD. has 93 stocks in it's portfolio. About 26.6% of the portfolio is in top 10 stocks. BBIO proved to be the most loss making stock for the portfolio. TEVA was the most profitable stock for SPHERA FUNDS MANAGEMENT LTD. last quarter.
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AAPL | apple inc | 0.42 | 17,500 | 3,000,900 | new | |||
| ABBV | abbvie inc | 0.97 | 38,000 | 6,919,800 | reduced | -17.39 | ||
| ACAD | acadia pharmaceuticals inc | 0.32 | 125,000 | 2,311,250 | new | |||
| AKRO | akero therapeutics inc | 0.57 | 160,445 | 4,052,840 | new | |||
| ALEC | alector inc | 0.47 | 560,000 | 3,371,200 | new | |||
| ALPN | alpine immune sciences inc | 0.25 | 44,841 | 1,777,500 | reduced | -80.91 | ||
| AMAT | applied matls inc | 0.93 | 32,000 | 6,599,360 | new | |||
| AMD | advanced micro devices inc | 0.28 | 11,000 | 1,985,390 | reduced | -78.17 | ||
| AMLX | amylyx pharmaceuticals inc | 0.11 | 267,250 | 758,990 | added | 45.52 | ||
| AMZN | amazon com inc | 1.38 | 54,432 | 9,818,440 | reduced | -2.23 | ||
| APLT | applied therapeutics inc | 0.59 | 619,029 | 4,209,400 | new | |||
| APRE | aprea therapeutics inc | 0.25 | 270,000 | 1,806,300 | new | |||
| ARBE | arbe robotics ltd | 0.01 | 43,165 | 90,215 | unchanged | 0.00 | ||
| ARWR | arrowhead pharmaceuticals in | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATXS | astria therapeutics inc | 0.22 | 112,842 | 1,588,250 | reduced | -90.2 | ||
| AVGO | broadcom inc | 0.19 | 1,001 | 1,326,740 | reduced | -44.39 | ||
| AZN | astrazeneca plc | 1.81 | 190,060 | 12,876,600 | added | 5.55 | ||
| BBIO | bridgebio pharma inc | 2.55 | 585,956 | 18,117,800 | added | 107 | ||
| BIIB | biogen inc | 2.14 | 70,646 | 15,233,400 | added | 52.43 | ||
| CAMT | camtek ltd | 0.88 | 74,909 | 6,275,130 | new | |||